Skadden, Freshfields and Davis Polk take the lead as blockbuster Pfizer/AstraZeneca deal gears up again

Skadden, Arps, Slate, Meagher & Flom, Freshfields Bruckhaus Deringer and Davis Polk & Wardwell have all landed lead roles advising Pfizer and AstraZeneca as talks over a potential $100bn merger resurface.

Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected]

Related Content

EQT selects global relationship firms as PE giant targets closer ties with key advisers

Sky’s the limit for HSF Kramer and Freshfields as pair take lead roles on £1.6bn ITV acquisition

Revolving Doors: latest laterals for Paul Hastings, McDermott, Proskauer and more

Latham and Simpson Thacher power up for $2.6bn EQT-Carlyle data centre deal

Paul Weiss lands mandate as Apollo swoops in with £5.7bn bid for easyJet

‘We don’t think about where we came from’ – Clifford Chance’s plan to crack the transatlantic buyout market

Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London moves

Five partners vie to succeed Hoyland as Simmons managing partner

‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetry